Atara Biotherapeutics Inc...

NASDAQ: ATRA · Real-Time Price · USD
7.43
0.17 (2.34%)
At close: May 08, 2025, 3:59 PM
8.00
7.60%
After-hours: May 08, 2025, 04:26 PM EDT
2.34%
Bid 7.12
Market Cap 44.32M
Revenue (ttm) 128.94M
Net Income (ttm) -371.17M
EPS (ttm) -11.41
PE Ratio (ttm) -0.65
Forward PE -3.44
Analyst Buy
Ask 8.88
Volume 54,315
Avg. Volume (20D) 58,537
Open 7.24
Previous Close 7.26
Day's Range 6.90 - 7.62
52-Week Range 5.00 - 18.70
Beta 0.30

About ATRA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATRA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ATRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Atara Biotherapeutics Inc. is scheduled to release its earnings on May 20, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+5.79%
Atara Biotherapeutics shares are trading higher af... Unlock content with Pro Subscription
5 months ago
+22.19%
Atara Biotherapeutics shares are trading higher after the company reported better-than-expected Q3 sales results. Also, Canaccord Genuity maintained a Buy rating on the stock and raised its price target from $13 to $21.